Search

everythinglearnresearchcommunity

for

Search:↓

As of December 2021, the most effective COVID-19 treatments were monoclonal antibodies and possibly early-administered convalescent plasma, while several drugs were found ineffective or were still under evaluation.

Plerixafor may help treat pigmentation disorders by promoting skin repigmentation.

Cepharanthine analogues, especially tetrandrine, show potential for treating COVID-19.

Some drugs can cause serious side effects, like hypoglycemia from mix-ups, skin reactions, or depression, and while penicillamine may help rheumatoid arthritis more than auranofin, it has more severe side effects.

Increasing TSPO in the brain reduces anxiety and depression.

Activating cannabinoid receptor 1 reduces certain keratin levels, potentially aiding psoriasis treatment.

Some cannabinoid derivatives may be more effective than current drugs at targeting proteins relevant to prostate cancer treatment.

Most patients successfully switched from the original adalimumab to a biosimilar with few reverting due to reduced effectiveness or side effects.

New male contraceptive pills show promise in reducing sperm production with mild side effects.

Cardamonin may help treat oral cancer by promoting cell death and stopping cancer cell growth.

Researchers created a skin patch that delivers two drugs for treating enlarged prostate, which may improve patient use and dosage control.

Leuprolide may better manage cholesterol and blood pressure in PCOS than spironolactone.

Clinicians should use social and prescription data to track trends in performance-enhancing drug use.

Melatonin and cortisol affect mink winter hair growth, but β-endorphin levels do not.

Cepharanthine and berbamine may affect SK channels, influencing their therapeutic effects.

Off-label drug use can be risky and requires careful consideration to ensure patient safety.

Metyrapone can effectively treat Cushing's Disease even if the mass causing it is not found.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.

New treatments for PCOS show promise, but no current medication treats all aspects of the condition.

Antibody drug conjugates show promise in targeting cancer cells while reducing harm to healthy cells.

Researchers made new compounds that could potentially be developed into anticancer drugs.

Diane® is an effective contraceptive that also helps treat acne and mild hair growth issues.

Progesterone's seizure-reducing effects are mainly due to allopregnanolone, not progesterone receptors.

Erythrocyte-anchored nanoparticles improved Cepharanthine delivery and effectiveness for treating acute lung injury.

GLP-1 receptor agonists may help manage and prevent diabetic foot ulcers.

A peptide known for reducing wrinkles also effectively inhibits an enzyme linked to skin inflammation and acne.

GD-23 reduces anxiety by relying on neurosteroid production.

Pazopanib treatment caused rapid hair color loss, possibly indicating its effectiveness.

The MPA-ISO cocrystal improved solubility and dissolution rate, while the others did not.